TEVA Pharmaceutical: Kursziel gesteigert
London (www.aktiencheck.de) - Rating-Update:
Balaji Prasad, Analyst von Barclays, bestätigt das Rating "overweight" für die Aktie von TEVA Pharmaceutical Industries Ltd.…
21,050€
-0,47%
Echtzeit-Aktienkurs Teva Pharmaceutical Industries Ltd. ADR
Bid:
Ask:
Nachrichten zur Teva Pharmaceutical Industries Ltd. ADR Aktie
Teva Pharma Agrees To Settle Price-Fixing Claims With Florida
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced Thursday that its U.S. affiliate Teva Pharma signed an agreement…
Teva to pay ~$6.7M to Florida to settle price fixing claims
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript
TEVA earnings call for the period ending December 31, 2022....…
UPDATE 2-Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints
...
JERUSALEM, Feb 8 (Reuters) - Teva Pharmaceutical
Industries, the worlds......…
Teva reports heavy losses, sees minimal 2023 growth
New Teva CEO Richard Francis: We continued to optimize our supply chain and manufacturing capabilities and reduced our net debt....…
Teva issues in line guidance as North American revenue remains flat
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
ROUNDUP: Teva Issues FY23 Adj. Earnings, Revenue Outlook
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Limited (TEVA), while announcing sharply wider net loss and weak revenues in its…
Teva Pharmaceutical Industries Limited Q4 Earnings Summary
PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$1.22 billion in Q4 vs.…
Teva Pharm Q4 profit meets estimates, revenue slips
...JERUSALEM (Reuters) - Israel-based Teva Pharmaceutical Industries......…
Form 8-K TEVA PHARMACEUTICAL INDU For: Feb 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva follows AbbVie to leave top pharma industry group
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharma Down 34% as Teva Eyes Generic Version of Firdapse
Catalyst Pharma Down 34% as Teva Eyes Generic Version of Firdapse...…
Why Catalyst Pharmaceuticals Shares Are Moving
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13.46% to $18.00 Monday morning after Teva Pharmaceuticals stated it…
Teva Seeks FDA OK for Generic Form of Catalysts Firdapse
Teva Seeks FDA OK for Generic Form of Catalyst's Firdapse...…
Catalyst stock slumps ~20% as Teva seeks FDA approval of generic Firdapse
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical…
Teva trades lower after Jefferies cuts rating to Hold
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
TEVA Shares Rise on Broad Support for Opioids Settlement
With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement....…
Teva: 48 US states have agreed to opioid settlement
The Israeli pharmaceutical company said that a sufficient level of participation in the settlement had been reached to allow it…
Teva Pharmaceutical says 48 states have agreed to its opioid settlement
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar?
Teva Pharmaceutical Industries Ltd. (TEVA) witnessed a jump in share price last session on above-average trading volume. The latest trend…
Teva Pharma Confirms Participation From 48 States On Opioids Settlement
PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), confirmed a sufficient level of…
UPDATE 1-Teva says opioids settlement to move forward in U.S.
...(Adds details and background)
Jan 9 (Reuters) - Israeli drugmaker......…
Teva says opioids settlement to move forward in U.S
...(Reuters) - Israeli drugmaker Teva Pharmaceutical Industries Ltd......…
Teva says opioids settlement to move forward in U.S.
...Jan 9 (Reuters) - Israeli drugmaker Teva Pharmaceutical
Industries......…
Alvotech, Teva Shares Rise After FDA Accepts BLA for AVT04
Alvotech, Teva Shares Rise After FDA Accepts BLA for AVT04...…
Alvotech: FDA Accepts BLA For AVT04, Proposed Biosimilar To Stelara
PETAH TIKVA (dpa-AFX) - Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), said that…
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company…
Jazz Pharma files patent infringement suit against Teva, Taro over generic Epidiolex
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
DUBLIN, Jan. 4, 2023 /PRNewswire/ -- The "Active Pharmaceutical Ingredient Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028:…
Knappe Fiebersäfte und Arzneien - Lieferengpässe treiben Apotheken um
FRANKFURT/DÜSSELDORF (dpa-AFX) - Ob Fiebersäfte für Kinder, Hustenmittel, Blutdrucksenker, Brustkrebsmedikamente oder Magensäureblocker: Wer in der Apotheke…
ANALYSE-FLASH: JPMorgan senkt Teva Pharma auf 'Underweight' - Ziel auf 10 Dollar
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat Teva von "Neutral" auf "Underweight" abgestuft…
ANALYSE-FLASH: UBS senkt Teva Pharma auf 'Sell' und Ziel auf 7 Dollar
ZÜRICH (dpa-AFX) - Die Schweizer Großbank UBS hat Teva von "Neutral" auf "Sell" abgestuft und…
Ratiopharm-Chef: Viele Gründe für Lieferengpässe bei Arzneien
BERLIN/ULM (dpa-AFX) - Der Geschäftsführer des Ulmer Arzneiherstellers Ratiopharm, Andreas Burkhardt, hat Lieferengpässe bei Medikamenten in…